BAZIMTO Trademark

Trademark Overview


On Thursday, April 23, 2020, a trademark application was filed for BAZIMTO with the United States Patent and Trademark Office. The USPTO has given the BAZIMTO trademark a serial number of 79286775. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, March 1, 2021. This trademark is owned by Novartis AG. The BAZIMTO trademark is filed in the Pharmaceutical Products category with the following description:

antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceut...
bazimto

General Information


Serial Number79286775
Word MarkBAZIMTO
Filing DateThursday, April 23, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, March 1, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesantibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 16, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSandoz AG
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Friday, January 19, 2024CHANGE OF OWNER RECEIVED FROM IB
Monday, March 21, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, March 1, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, March 1, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, November 28, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, November 10, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 10, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, March 1, 2021ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, March 1, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, February 3, 2021ATTORNEY REVIEW COMPLETED
Saturday, January 23, 2021LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Friday, November 13, 2020LIMITATION OF GOODS RECEIVED FROM IB
Saturday, September 5, 2020REFUSAL PROCESSED BY IB
Tuesday, August 18, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, August 18, 2020REFUSAL PROCESSED BY MPU
Wednesday, July 8, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 7, 2020NON-FINAL ACTION WRITTEN
Monday, July 6, 2020ASSIGNED TO EXAMINER
Saturday, June 20, 2020APPLICATION FILING RECEIPT MAILED
Tuesday, June 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 12, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, June 4, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB